Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Melanoma

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 47 articles: HTML format Text format

Single Articles

December 2011
1. MAUR M , Tomasello C, Frassoldati A, Dieci MV, et al
   Posterior Reversible Encephalopathy Syndrome During Ipilimumab Therapy for Malignant Melanoma.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
2. TARHINI AA , Cherian J, Moschos SJ, Tawbi HA, et al
   Safety and Efficacy of Combination Immunotherapy With Interferon Alfa-2b and Tremelimumab in Patients With Stage IV Melanoma.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. SI L , Xu X, Kong Y, Flaherty KT, et al
   Major Response to Everolimus in Melanoma With Acquired Imatinib Resistance.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   November 2011
4. KIM KB , Sosman JA, Fruehauf JP, Linette GP, et al
   BEAM: A Randomized Phase II Study Evaluating the Activity of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Melanoma.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. VOGEL WV , Guislain A, Kvistborg P, Schumacher TN, et al
   Ipilimumab-Induced Sarcoidosis in a Patient With Metastatic Melanoma Undergoing Complete Remission.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
6. TURNER RM , Bell KJ, Morton RL, Hayen A, et al
   Optimizing the Frequency of Follow-Up Visits for Patients Treated for Localized Primary Cutaneous Melanoma.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. SONDAK VK , Leachman SA
   Individualizing Follow-Up for Patients With Early-Stage Melanoma.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   October 2011
8. CRUZ C , Teule A, Caminal JM, Blanco I, et al
   Uveal Melanoma and BRCA1/BRCA2 Genes: A Relationship That Needs Further Investigation.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
9. SMYTH EC , Flavin M, Pulitzer MP, Gardner GJ, et al
   Treatment of Locally Recurrent Mucosal Melanoma With Topical Imiquimod.
   J Clin Oncol. 2011.
   PubMed     Text format     Related articles   
   
   
   
   
10. BURKE MM , Kluger HM, Golden M, Heller KN, et al
    Case Report: Response to Ipilimumab in a Patient With HIV With Metastatic Melanoma.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
11. DEL VECCHIO M , Mortarini R, Tragni G, Di Guardo L, et al
    T-Cell Activation and Maturation at Tumor Site Associated With Objective Response to Ipilimumab in Metastatic Melanoma.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    September 2011
12. PUSIOL T , Morichetti D, Zorzi MG, Piscioli F, et al
    Melanoma Staging: Implications of Histologic Sectioning Procedures.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
13. SATZGER I , Meier A, Alter M, Kapp A, et al
    Parameters Predicting Prognosis in Melanoma Sentinel Nodes.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    July 2011
14. LINDSKOG DM , Nikkhou K, Talusan P
    False-positive positron emission tomography in patients with history of malignancy.
    J Clin Oncol. 2011;29:e582-5.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
15. TANG JY , Fu T, Leblanc E, Manson JE, et al
    Calcium Plus Vitamin D Supplementation and the Risk of Nonmelanoma and Melanoma Skin Cancer: Post Hoc Analyses of the Women's Health Initiative Randomized Controlled Trial.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. SLINGLUFF CL JR , Petroni GR, Chianese-Bullock KA, Smolkin ME, et al
    Randomized Multicenter Trial of the Effects of Melanoma-Associated Helper Peptides and Cyclophosphamide on the Immunogenicity of a Multipeptide Melanoma Vaccine.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. GUO J , Si L, Kong Y, Flaherty KT, et al
    Phase II, Open-Label, Single-Arm Trial of Imatinib Mesylate in Patients With Metastatic Melanoma Harboring c-Kit Mutation or Amplification.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
18. GOLDENHERSH MA , Koslowsky M
    Increased Melanoma After Regular Sunscreen Use?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
19. AVERBOOK BJ
    Mitotic Rate and Sentinel Lymph Node Tumor Burden Topography: Integration Into Melanoma Staging and Stratification Use in Clinical Trials.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
20. VAN DER PLOEG AP , van Akkooi AC, Rutkowski P, Nowecki ZI, et al
    Prognosis in Patients With Sentinel Node-Positive Melanoma Is Accurately Defined by the Combined Rotterdam Tumor Load and Dewar Topography Criteria.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
21. THOMPSON JF , Soong SJ, Balch CM, Gershenwald JE, et al
    Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
22. AUTIER P , Boniol M, Dore JF
    Is Sunscreen Use for Melanoma Prevention Valid for All Sun Exposure Circumstances?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
23. FLAHERTY KT
    Is it good or bad to find a BRAF mutation?
    J Clin Oncol. 2011;29:1229-30.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
24. FULD AD , Speck ME, Harris BT, Simmons NE, et al
    Primary Melanoma of the Spinal Cord: A Case Report, Molecular Footprint, and Review of the Literature.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
25. CHMIEL KD , Suan D, Liddle C, Nankivell B, et al
    Resolution of severe ipilimumab-induced hepatitis after antithymocyte globulin therapy.
    J Clin Oncol. 2011;29:e237-40.
    PubMed     Text format     Related articles   
    
    
    
    
26. SATZGER I , Meier A, Alter M, Kapp A, et al
    Which Parameters to Choose for Prediction of Non-Sentinel Lymph Node Positivity in Melanoma?
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
27. WAGLE N , Emery C, Berger MF, Davis MJ, et al
    Dissecting Therapeutic Resistance to RAF Inhibition in Melanoma by Tumor Genomic Profiling.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. VALSECCHI ME , Silbermins D, de Rosa N, Wong SL, et al
    Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Melanoma: A Meta-Analysis.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. SHERRIFF JM , Walji N
    Prolonged survival in a patient with multiple metachronous tumors.
    J Clin Oncol. 2011;29:e154-5.
    PubMed     Text format     Related articles   
    
    
    
    February 2011
30. BEASLEY GM , Riboh JC, Augustine CK, Zager JS, et al
    Prospective Multicenter Phase II Trial of Systemic ADH-1 in Combination With Melphalan via Isolated Limb Infusion in Patients With Advanced Extremity Melanoma.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. LONG GV , Menzies AM, Nagrial AM, Haydu LE, et al
    Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
32. ROBBINS PF , Morgan RA, Feldman SA, Yang JC, et al
    Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1.
    J Clin Oncol. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
33. NAIR BC , Williams NC, Cui C, Summers D, et al
    Conjunctival Melanoma: Bladder and Upper Urinary Tract Metastases.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
34. DE GIORGI V , Gori A, Alfaioli B, Papi F, et al
    Influence of Sex Hormones on Melanoma.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
35. GIMOTTY PA , Glanz K
    Sunscreen and Melanoma: What Is the Evidence?
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
36. GREEN AC , Williams GM, Logan V, Strutton GM, et al
    Reduced Melanoma After Regular Sunscreen Use: Randomized Trial Follow-Up.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
37. MURALI R , Desilva C, Thompson JF, Scolyer RA, et al
    Non-Sentinel Node Risk Score (N-SNORE): A Scoring System for Accurately Stratifying Risk of Non-Sentinel Node Positivity in Patients With Cutaneous Melanoma With Positive Sentinel Lymph Nodes.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
38. HUTCHINSON PE , Osborne JE, Pringle JH
    Higher Serum 25-Hydroxy Vitamin D3 Levels at Presentation Are Associated With Improved Survival From Melanoma, But There Is No Evidence That Later Prevailing Levels Are Protective.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
39. BRAHMER JR , Drake CG, Wollner I, Powderly JD, et al
    Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.
    J Clin Oncol. 2010;28:3167-75.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
40. THOMAS JM , Strauss DC, Hayes AJ
    Some of the 2009 American Joint Committee on Cancer Melanoma Staging and Classification Is Not Evidence Based.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles   
    
    
    
    May 2010
41. ROMANO E , Scordo M, Dusza SW, Coit DG, et al
    Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up Guidelines.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. BOUWHUIS MG , Suciu S, Testori A, Kruit WH, et al
    Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: prognostic significance of autoantibodies--EORTC 18991.
    J Clin Oncol. 2010;28:2460-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2010
43. BALCH CM , Gershenwald JE, Soong SJ, Thompson JF, et al
    Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
44. MAIO M , Mackiewicz A, Testori A, Trefzer U, et al
    Large Randomized Study of Thymosin {alpha} 1, Interferon Alfa, or Both in Combination With Dacarbazine in Patients With Metastatic Melanoma.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. STANG A , Schmidt-Pokrzywniak A, Kuss O
    Arbitrary results of a meta-analysis on cancer risks among mobile phone users.
    J Clin Oncol. 2010;28:e121.
    PubMed     Text format     Related articles   
    
    
    
    February 2010
46. GUNTURU KS , Meehan KR, Mackenzie TA, Crocenzi TS, et al
    Cytokine Working Group Study of Lymphodepleting Chemotherapy, Interleukin-2, and Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Metastatic Melanoma: Clinical Outcomes and Peripheral-Blood Cell Recovery.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2010
47. VOIT C , Van Akkooi AC, Schafer-Hesterberg G, Schoengen A, et al
    Ultrasound Morphology Criteria Predict Metastatic Disease of the Sentinel Nodes in Patients With Melanoma.
    J Clin Oncol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: